View ICR - OIRA Conclusion



0910-0681 201704-0910-004
Historical Active 201403-0910-008
HHS/FDA CBER
Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components Intended for Transfusion
Extension without change of a currently approved collection   No
Regular
Approved without change 06/27/2017
04/25/2017
  Inventory as of this Action Requested Previously Approved
06/30/2020 36 Months From Approved 06/30/2017
1 0 1
1 0 1
0 0 0